Literature DB >> 26235249

Investigation of the relationship between neutrophil-to-lymphocyte ratio and obstructive sleep apnoea syndrome.

A Yenigun1, H Karamanli2.   

Abstract

OBJECTIVE: To investigate the neutrophil-to-lymphocyte ratio and sleep apnoea severity relationship.
METHODS: Patients (n = 178) were assigned to five groups according to apnoea-hypopnea indices and continuous positive airway pressure use. White blood cell, neutrophil, lymphocyte and neutrophil-to-lymphocyte ratio values were compared for each group.
RESULTS: The neutrophil-to-lymphocyte ratio values of severe obstructive sleep apnoea syndrome patients (group 4) were significantly higher than those of: control patients (group 1), mild obstructive sleep apnoea syndrome patients (group 2) and patients treated with continuous positive airway pressure (group 5) (p = 0.008, p = 0.008 and p = 0.003). Minimum oxygen saturation values of group 4 were significantly lower than those of groups 1, 2 and 5 (p = 0.0005, p = 0.011 and p = 0.001). There was a positive correlation between apnoea-hypopnea index and neutrophil-to-lymphocyte ratio (r = 0.758, p = 0.034), and a negative correlation between apnoea-hypopnea index and minimum oxygen saturation (r = -0.179, p = 0.012).
CONCLUSION: Neutrophil-to-lymphocyte ratio may be used to determine disease severity, complementing polysomnography.

Entities:  

Keywords:  Lymphocytes; Neutrophils; Obstructive Sleep Apnea Syndrome; Sleep Apnea; Upper Airway Resistance Sleep Apnea Syndrome

Mesh:

Substances:

Year:  2015        PMID: 26235249     DOI: 10.1017/S0022215115001747

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

1.  Treatment of obstructive sleep apnea with CPAP improves chronic inflammation measured by neutrophil-to-lymphocyte ratio.

Authors:  Moh'd Al-Halawani; Christian Kyung; Fei Liang; Ian Kaplan; Jane Moon; Guerrier Clerger; Bruce Sabin; Andrea Barnes; Mohammad Al-Ajam
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

2.  Neutrophil-to-lymphocyte ratio decreases in obstructive sleep apnea treated with mandibular advancement devices.

Authors:  Moh'd Al-Halawani; Sreelatha Naik; Michael Chan; Iouri Kreinin; Jonathan Meiers; Meir Kryger
Journal:  Sleep Breath       Date:  2018-02-07       Impact factor: 2.816

3.  [Peripheral blood cell count and inflammation-based markers in chronic rhinosinusitis].

Authors:  O Zagólski; P Stręk; W Jurczak; P Gorzedowski
Journal:  HNO       Date:  2018-08       Impact factor: 1.284

4.  Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis.

Authors:  Mindan Wu; Lingren Zhou; Ding Zhu; Tianwen Lai; Zhihua Chen; Huahao Shen
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Is There A Systemıc Inflammatory Effect of Cholesteatoma?

Authors:  M Mustafa Kılıçkaya; Giray Aynali; Mustafa Tuz; Özkan Bagcı
Journal:  Int Arch Otorhinolaryngol       Date:  2016-06-06

6.  Association between the neutrophil-to-lymphocyte ratio and obstructive sleep apnea: a meta-analysis.

Authors:  Min-Seok Rha; Chang-Hoon Kim; Joo-Heon Yoon; Hyung-Ju Cho
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

7.  Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis.

Authors:  Glaucylara Reis Geovanini; Rui Wang; Jia Weng; Nancy S Jenny; Steven Shea; Matthew Allison; Peter Libby; Susan Redline
Journal:  Ann Am Thorac Soc       Date:  2018-08

8.  Liver and spleen elastography of dogs affected by brachycephalic obstructive airway syndrome and its correlation with clinical biomarkers.

Authors:  Andréia Coutinho Facin; Ricardo Andres Ramirez Uscategui; Marjury Cristina Maronezi; Letícia Pavan; Mareliza Possa Menezes; Gabriel Luiz Montanhim; Aparecido Antonio Camacho; Marcus Antônio Rossi Feliciano; Paola Castro Moraes
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.